185 related articles for article (PubMed ID: 38174960)
21. Dual-action nanoplatform with a synergetic strategy to promote oxygen accumulation for enhanced photodynamic therapy against hypoxic tumors.
Ren C; Xu X; Yan D; Gu M; Zhang J; Zhang H; Han C; Kong L
Acta Biomater; 2022 Jul; 146():465-477. PubMed ID: 35526738
[TBL] [Abstract][Full Text] [Related]
22. A hybrid metal-organic framework nanomedicine-mediated photodynamic therapy and hypoxia-activated cancer chemotherapy.
Jia Z; Gao Y; Ni J; Wu X; Mao Z; Sheng G; Zhu Y
J Colloid Interface Sci; 2023 Jan; 629(Pt B):379-390. PubMed ID: 36162395
[TBL] [Abstract][Full Text] [Related]
23. Metal-Organic Frameworks with Enhanced Photodynamic Therapy: Synthesis, Erythrocyte Membrane Camouflage, and Aptamer-Targeted Aggregation.
Zhao Y; Wang J; Cai X; Ding P; Lv H; Pei R
ACS Appl Mater Interfaces; 2020 May; 12(21):23697-23706. PubMed ID: 32362109
[TBL] [Abstract][Full Text] [Related]
24. Engineered MOF-Enzyme Nanocomposites for Tumor Microenvironment-Activated Photodynamic Therapy with Self-Luminescence and Oxygen Self-Supply.
Hu L; Xiong C; Zou JJ; Chen J; Lin H; Dalgarno SJ; Zhou HC; Tian J
ACS Appl Mater Interfaces; 2023 May; 15(21):25369-25381. PubMed ID: 37199535
[TBL] [Abstract][Full Text] [Related]
25. Programmable therapeutic nanoscale covalent organic framework for photodynamic therapy and hypoxia-activated cascade chemotherapy.
He H; Du L; Xue H; Wu J; Shuai X
Acta Biomater; 2022 Sep; 149():297-306. PubMed ID: 35811069
[TBL] [Abstract][Full Text] [Related]
26. Hypoxia alleviation-triggered enhanced photodynamic therapy in combination with IDO inhibitor for preferable cancer therapy.
Xing L; Gong JH; Wang Y; Zhu Y; Huang ZJ; Zhao J; Li F; Wang JH; Wen H; Jiang HL
Biomaterials; 2019 Jun; 206():170-182. PubMed ID: 30939409
[TBL] [Abstract][Full Text] [Related]
27. Zeolitic Imidazolate Framework Platform for Combinational Starvation Therapy and Oxygen Self-Sufficient Photodynamic Therapy against a Hypoxia Tumor.
Ouyang Y; Wang P; Huang B; Yang G; Tian J; Zhang W
ACS Appl Bio Mater; 2021 May; 4(5):4413-4421. PubMed ID: 35006853
[TBL] [Abstract][Full Text] [Related]
28. Recent Progress of Metal-Organic Framework-Based Photodynamic Therapy for Cancer Treatment.
Ye Y; Zhao Y; Sun Y; Cao J
Int J Nanomedicine; 2022; 17():2367-2395. PubMed ID: 35637838
[TBL] [Abstract][Full Text] [Related]
29. Biodegradable oxygen-producing manganese-chelated metal organic frameworks for tumor-targeted synergistic chemo/photothermal/ photodynamic therapy.
Feng L; Chen M; Li R; Zhou L; Wang C; Ye P; Hu X; Yang J; Sun Y; Zhu Z; Fang K; Chai K; Shi S; Dong C
Acta Biomater; 2022 Jan; 138():463-477. PubMed ID: 34718179
[TBL] [Abstract][Full Text] [Related]
30. Nanozyme Decorated Metal-Organic Frameworks for Enhanced Photodynamic Therapy.
Zhang Y; Wang F; Liu C; Wang Z; Kang L; Huang Y; Dong K; Ren J; Qu X
ACS Nano; 2018 Jan; 12(1):651-661. PubMed ID: 29290107
[TBL] [Abstract][Full Text] [Related]
31. A photo-degradable BODIPY-modified Ru(II) photosensitizer for safe and efficient PDT under both normoxic and hypoxic conditions.
Peng Y; Da X; Zhou W; Xu Y; Liu X; Wang X; Zhou Q
Dalton Trans; 2024 Feb; 53(8):3579-3588. PubMed ID: 38314620
[TBL] [Abstract][Full Text] [Related]
32. Photosensitizer-based metal-organic frameworks for highly effective photodynamic therapy.
Alves SR; Calori IR; Tedesco AC
Mater Sci Eng C Mater Biol Appl; 2021 Dec; 131():112514. PubMed ID: 34857293
[TBL] [Abstract][Full Text] [Related]
33. Oxygen-Generating Organic/Inorganic Self-Assembled Nanocolloids for Tumor-Activated Dual-Model Imaging-Guided Photodynamic Therapy.
Fu Y; Jang MS; Liu C; Li Y; Lee JH; Yang HY
ACS Appl Mater Interfaces; 2023 Aug; 15(30):36013-36024. PubMed ID: 37478563
[TBL] [Abstract][Full Text] [Related]
34. Activatable Type I Photosensitizer with Quenched Photosensitization Pre and Post Photodynamic Therapy.
Tian J; Li B; Zhang F; Yao Z; Song W; Tang Y; Ping Y; Liu B
Angew Chem Int Ed Engl; 2023 Nov; 62(46):e202307288. PubMed ID: 37681940
[TBL] [Abstract][Full Text] [Related]
35. Covalent Organic Framework Nanocarriers of Singlet Oxygen for Oxygen-Independent Concurrent Photothermal/Photodynamic Therapy to Ablate Hypoxic Tumors.
Dutta D; Wang J; Li X; Zhou Q; Ge Z
Small; 2022 Sep; 18(37):e2202369. PubMed ID: 35971160
[TBL] [Abstract][Full Text] [Related]
36. Biomimetic oxygen delivery nanoparticles for enhancing photodynamic therapy in triple-negative breast cancer.
Fang H; Gai Y; Wang S; Liu Q; Zhang X; Ye M; Tan J; Long Y; Wang K; Zhang Y; Lan X
J Nanobiotechnology; 2021 Mar; 19(1):81. PubMed ID: 33743740
[TBL] [Abstract][Full Text] [Related]
37. Metal-Organic Framework PCN-224 Combined Cobalt Oxide Nanoparticles for Hypoxia Relief and Synergistic Photodynamic/Chemodynamic Therapy.
Yuan H; Chen K; Geng J; Wu Z; Wang C; Shi P
Chemistry; 2024 Jun; 30(36):e202400319. PubMed ID: 38606488
[TBL] [Abstract][Full Text] [Related]
38. An Ethacrynic Acid-Brominated BODIPY Photosensitizer (EA-BPS) Construct Enhances the Lethality of Reactive Oxygen Species in Hypoxic Tumor-Targeted Photodynamic Therapy.
Won M; Koo S; Li H; Sessler JL; Lee JY; Sharma A; Kim JS
Angew Chem Int Ed Engl; 2021 Feb; 60(6):3196-3204. PubMed ID: 33155344
[TBL] [Abstract][Full Text] [Related]
39. Recent Advances in Hypoxia-Overcoming Strategy of Aggregation-Induced Emission Photosensitizers for Efficient Photodynamic Therapy.
Chen H; Wan Y; Cui X; Li S; Lee CS
Adv Healthc Mater; 2021 Dec; 10(24):e2101607. PubMed ID: 34674386
[TBL] [Abstract][Full Text] [Related]
40. Recent advances in type I organic photosensitizers for efficient photodynamic therapy for overcoming tumor hypoxia.
Lu B; Wang L; Tang H; Cao D
J Mater Chem B; 2023 May; 11(21):4600-4618. PubMed ID: 37183673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
